Search Results

Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents

Author: Washburn, William N

Source: Expert Opinion on Therapeutic Patents, Volume 19, Number 11, November 2009 , pp. 1485-1499(15)

Publisher: Informa Healthcare

The hepoxilins and some analogues: a review of their biology

Author: Pace-Asciak, Cecil R

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 972-981(10)

Publisher: Blackwell Publishing

Psoriasis May Not Be an Independent Predictor for the Use of Cardiovascular and Anti-diabetic Drugs: A 5-year Prevalence Study

Authors: Wakkee, Marlies; Meijer, Willemijn; Neumann, H. A. Martino; Herings, Ron M.C.; Nijsten, Tamar

Source: Acta Dermato-Venereologica, Volume 89, Number 5, September 2009 , pp. 476-483(8)

Publisher: Medical Journals Limited

Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation

Authors: Adameova, A.; Xu, Y. J.; Duhamel, T. A.; Tappia, P. S.; Shan, L.; Dhalla, N. S.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3094-3107(14)

Publisher: Bentham Science Publishers

Determination of synthetic drugs used to adulterate botanical dietary supplements using QTRAP LC-MS/MS

Authors: Chen, Y.; Zhao, L.; Lu, F.; Yu, Y.; Chai, Y.; Wu, Y.

Source: Food Additives and Contaminants, Volume 26, Number 5, May 2009 , pp. 595-603(9)

Publisher: Taylor and Francis Ltd

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

Authors: Jones, Stephen; Benroubi, Marian; Castell, Conxa; Goday, Albert; Liebl, Andreas; Timlin, Louise; Nicolay, Claudia; Simpson, Alexander; Tynan, Aodan

Source: Current Medical Research and Opinion, Volume 25, Number 3, March 2009 , pp. 691-700(10)

Publisher: Informa Healthcare

Distinct modulation of voltage-gated and ligand-gated Ca²⁺ currents by PPAR-γ agonists in cultured hippocampal neurons

Authors: Pancani, Tristano; Phelps, Jeremiah T.; Searcy, James L.; Kilgore, Michael W.; Chen, Kuey-Chu; Porter, Nada M.; Thibault, Olivier

Source: Journal of Neurochemistry, Volume 109, Number 6, June 2009 , pp. 1800-1811(12)

Publisher: Blackwell Publishing

Novel class of hybrid natural products as antidiabetic agents

Authors: Raj, Kanwal; Misra, Namita; Pachauri, Geetali; Sharma, Mithelesh; Tamrakar, Akhilesh Kumar; Singh, Amar Bahadur; Srivastava, Arvind Kumar; Phani Kiran, K.; Narasimha Rao, C.V.; Prubhu, S. R.

Source: Natural Product Research, Volume 23, Number 1, October 2009 , pp. 60-69(10)

Publisher: Taylor and Francis Ltd

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

Authors: Gupta, Rajesh; Walunj, Sameer S.; Tokala, Ranjeet K.; Parsa, Kishore V.L.; Singh, Santosh K.; Pal, Manojit

Source: Current Drug Targets, Volume 10, Number 1, January 2009 , pp. 71-87(17)

Publisher: Bentham Science Publishers

Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus

Authors: Ceylan-Isik, Asli F.; Fliethman, Rochelle M.; Wold, Loren E.; Ren, Jun

Source: Current Diabetes Reviews, Volume 4, Number 4, November 2008 , pp. 320-328(9)

Publisher: Bentham Science Publishers

Effects of Thiazolidinediones on Coronary Artery Disease: Review

Authors: Nishio, Kazuaki; Kobayashi, Youichi

Source: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Volume 2, Number 3, November 2008 , pp. 211-217(7)

Publisher: Bentham Science Publishers

Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress

Authors: Cho, Nobuo; Momose, Yu

Source: Current Topics in Medicinal Chemistry, Volume 8, Number 17, November 2008 , pp. 1483-1507(25)

Publisher: Bentham Science Publishers

New Drugs for Type 2 Diabetes Mellitus: What is their Place in Therapy?

Authors: Krentz, Andrew J.; Patel, Mayank B.; Bailey, Clifford J.

Source: Drugs, Volume 68, Number 15, 2008 , pp. 2131-2162(32)

Publisher: Adis International

Bone Effects of Glitazones and Other Anti-Diabetic Drugs

Author: Rejnmark, Lars

Source: Current Drug Safety, Volume 3, Number 3, September 2008 , pp. 194-198(5)

Publisher: Bentham Science Publishers

Are functional foods redefining nutritional requirements?

Authors: Jones, Peter J.; Varady, Krista A.

Source: Applied Physiology, Nutrition, and Metabolism, Volume 33, Number 1, 1 January 2008 , pp. 118-123(6)

Publisher: NRC Research Press

Management of type 2 diabetes in the obese patient: current concerns and emerging therapies

Author: Krentz, Andrew J.

Source: Current Medical Research and Opinion, Volume 24, Number 2, February 2008 , pp. 401-417(17)

Publisher: Informa Healthcare

Editorial [Hot Topic: Rational Drug Design (Executive Editor: M. Rami Reddy)]

Author: Reddy, M. R.

Source: Current Pharmaceutical Design, Volume 13, Number 34, December 2007 , pp. 3453-3453(1)

Publisher: Bentham Science Publishers

Modeling and Informatics in Designing Anti-Diabetic Agents

Authors: Bharatam, P. V.; Patel, D. S.; Adane, L.; Mittal, A.; Sundriyal, S.

Source: Current Pharmaceutical Design, Volume 13, Number 34, December 2007 , pp. 3518-3530(13)

Publisher: Bentham Science Publishers

Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice

Authors: Cho, Eun; Hwang, Hye; Kim, Sang; Oh, Jung; Baek, Yu; Choi, Jang; Bae, Song; Yun, Jong

Source: Applied Microbiology and Biotechnology, Volume 75, Number 6, July 2007 , pp. 1257-1265(9)

Publisher: Springer

Lipotoxicity and Mitochondrial Dysfunction in Type 2 Diabetes

Authors: C. Hesselink, Matthijs K.; Mensink, Marco; Schrauwen, Patrick

Source: Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly, Volume 7, Number 1, February 2007 , pp. 3-17(15)

Publisher: Bentham Science Publishers